Senti Bio Debuts as Publicly Traded Company Focused on Developing Next-Generation Cell and Gene Therapies Engineered with Gene Circuits
… , Dr. Kanya Rajangam as Chief Medical and Development … effecting a merger, capital stock exchange, asset acquisition, stock purchase … the business combination, as well as statements about the [...]
